Takara Bio Inc.

The global cell expansion market is projected to grow at a CAGR of 12.1% from 2024 to 2034, reaching $40.1 billion by 2034. AI and ML are revolutionizing the process, while decentralized healthcare drives portable technologies. Key players include Thermo Fisher Scientific, Miltenyi Biotec, and Merck KGaA. Stem cells and bioreactors dominate the market, with biotechnology and pharmaceutical companies leading in end-user segments. North America and Europe are major regions, with Asia Pacific witnessing rapid growth.